Multirobot Offline Programming Software Allows 3-D Simulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Multirobot Offline Programming Software Allows 3-D Simulation


Pharmaceutical Technology
Volume 38, Issue 4, pp. 2

DENSO Robotics introduces its new Enhanced Multirobot (EMU) simulation and offline programming software, which serves as a master controller for robot project files imported from the company’s WINCAPS III application. EMU allows users to simulate and program up to 16 DENSO robots in a single automation workcell. WINCAPS III allows a robot to be programmed on an offline computer. A 3-D simulation feature enables layout of an entire automation workcell in a virtual environment. The software lets users import CAD drawings in standard VRML and DirectX formats, and easily input or change variables. Users can also verify reach, determine obstacle clearances, detect collisions, troubleshoot and debug programs, and determine cycle time. In addition, an Easy Teach feature allows users to move the robot to a particular point by simply clicking on the surface of the virtual model.

Denso

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here